 Efficacy aztreonam treatment skeletal infections due Pseudomonas aeruginosa Twenty-eight patients skeletal infections due aeruginosa aztreonam open noncomparative multicenter clinical trials patients septic arthritis aztreonam times day modal days mean mean follow-up period weeks Microbiologic cure patients complete clinical cure partial clinical cure Eighteen cases osteomyelitis aztreonam times day modal days mean mean follow-up period months Microbiologic cure patients Relapse month therapy patient Complete clinical cure partial clinical cure patients common adverse reactions transient elevation levels hepatic enzymes transient eosinophilia superinfections subsequent infection results support use aztreonam treatment skeletal infections due aeruginosa